Matthew Gline - 20 Apr 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CEO, Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Matthew Gline
Issuer symbol
ROIV
Transactions as of
20 Apr 2025
Net transactions value
-$111,092
Form type
4
Filing time
22 Apr 2025, 21:00:37 UTC
Previous filing
24 Mar 2025
Next filing
22 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Tax liability $111,092 -10,945 -0.06% $10.15 17,294,711 20 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.